Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2988692 | Journal of Vascular Surgery | 2015 | 9 Pages |
Abstract
This novel risk-stratified comparison using a national clinical database showed that EVAR of RAAA has a lower mortality and morbidity compared with OR in low-risk and medium-risk patients and that EVAR should be used to treat these patients when anatomically feasible. For RAAA patients at the highest preoperative risk, there is no benefit to using EVAR compared with OR.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Mujtaba M. MD, Julie MS, Andres MD, Jessica P. MD, MPH, Francesco A. MD, Danielle R. MD, Louis M. MD, William P. MD,